Every Form 4 that Hanover Bancorp, Inc. (HNVR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow HNVR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HNVR filings page.
Hanover Bancorp, Inc. /MD (symbol: HNVR) is the issuer of record for a Form 4 filing submitted to the SEC. O'Connor Kevin M reported acquisition or exercise transactions in this Form 4 filing.
Hanover Bancorp, Inc. (HNVR) reported that President Kevin M. O'Connor received a grant of 10,000 shares of common stock on September 1, 2026. The award is in the form of restricted stock subject to forfeiture and vests in five equal installments each September 1 from 2027 through 2031. Following this grant, O'Connor directly holds 22,300 shares of Hanover Bancorp common stock. No Rule 10b5-1 trading plan is reported for this transaction.
Hanover Bancorp, Inc. /MD President Kevin M. O'Connor purchased 10,000 shares of Common Stock on July 30, 2026 at $26.88 per share in an open-market or private transaction. Following this buy, he directly owns 12,300 shares. The Rule 10b5-1 plan checkbox was not selected.
Hanover Bancorp, Inc. director Robert Golden reported indirect open-market sales totaling 4,424 shares of common stock at prices around $24 per share. The sales were made from a trust for his benefit, which still holds 182,515 shares. He also reports additional indirect trust, LLC and spousal holdings, plus 28,341 shares held directly.
Hanover Bancorp director Robert Golden reported an insider transaction involving a trust for his benefit. On June 10, 2026, the trust sold 8,419 shares of common stock at an average of $24.2023 per share in an open-market or private transaction. That trust continues to hold 186,939 shares for his benefit, and Golden also has additional indirect trust and LLC interests plus 28,341 shares held directly.
Hanover Bancorp director Robert Golden reported an open-market sale of 1,847 shares of Common Stock at $23.101 per share on June 2, 2026. Following this transaction, he directly holds 28,341 Hanover Bancorp shares.
In addition to his direct holdings, the filing lists significant indirect ownership through various trusts and related entities. These include 195,358 shares in trusts for his benefit, 80,769 shares in trusts for a sibling where he is trustee, 42,771 shares held by a limited liability company he controls, and additional blocks held by his spouse and in trusts for his descendants and children.
Hanover Bancorp, Inc. director Robert Golden reported an open-market sale of 1,514 shares of common stock on May 29, 2026 at an average price of $23.7073 per share. After this sale, he directly held 30,188 shares of Hanover Bancorp common stock.
Golden also reported several indirect holdings. These include shares held in trusts for his benefit, for the benefit of his spouse, children, and sibling, as well as shares held by a limited liability company controlled by him and by his spouse individually, as described in the footnotes.
Hanover Bancorp, Inc. director Robert Golden reported an open-market sale of 1,295 shares of common stock at $23.5298 per share. These shares were sold from his direct holdings.
After the sale, he directly owns 31,702 common shares. The filing also details substantial additional indirect holdings through various trusts, a limited liability company, and shares held by his spouse and family members.
Hanover Bancorp, Inc. director Robert Golden reported open-market sales of company common stock. He sold a total of 3,271 shares in two transactions: 2,259 shares at a weighted average price of about $22.79 per share and 1,012 shares at about $23.01 per share. After these sales, he directly holds 32,997 shares. The filing also reports substantial indirect holdings in various trusts and entities associated with him and his family, including 195,358 shares in trusts for his benefit and additional large positions held for his spouse, children, and sibling, indicating the sales represent a small portion of his overall economic exposure to Hanover Bancorp.
Hanover Bancorp, Inc. director Robert Golden exercised stock options to acquire 10,000 shares of Common Stock on May 6, 2026 at $13.00 per share. Following the exercise, he directly holds 36,268 Common Stock shares, and the exercised Stock Options balance decreased to zero.
The filing also lists significant indirect holdings, including 195,358 shares in trusts for his benefit where his spouse is a trustee, 80,769 shares in trusts for a sibling where he is a trustee, 42,771 shares held by a limited liability company he controls, and additional shares held in various trusts and by his spouse and children.
Hanover Bancorp, Inc. executive Lisa A. Diiorio exercised stock options and had shares withheld for taxes. On May 1, 2026, she exercised 6,000 shares of common stock at $13.00 per share through a derivative exercise.
On the same date, 3,879 shares of common stock were disposed of at $23.72 per share as a tax-withholding disposition, meaning the shares covered tax obligations rather than being sold on the open market. After these transactions, she directly owned 17,899 shares of Hanover Bancorp common stock, and the stock options referenced in the footnote were fully exercised.
Hanover Bancorp, Inc. Chairman and CEO Michael P. Puorro reported multiple tax-related share dispositions of common stock. On February 20, 2026, he delivered an aggregate of 4,383 shares at $21.98 per share to cover tax withholding on vested restricted stock.
The restricted shares that vested on that date came from prior grants made on January 27, 2022, January 24, 2023, January 19, 2024, and January 29, 2025. After these transactions, Puorro directly owned 321,663 Hanover Bancorp common shares.
Hanover Bancorp, Inc. Senior Executive Vice President and Chief Financial Officer Lance P. Burke reported several small dispositions of common stock on February 20, 2026. Each transaction was coded "F" and represents shares withheld at $21.98 per share to cover tax obligations when previously granted restricted stock vested. These are administrative tax-withholding dispositions rather than open-market sales, and Burke continues to hold a direct ownership position in Hanover Bancorp common stock after these transactions.
Hanover Bancorp, Inc. executive Joseph F. Burns, EVP & Chief Lending Officer, reported a small share disposition tied to taxes rather than an open-market trade. On February 20, 2026, 188 shares of common stock were withheld at $21.98 per share to cover tax obligations on restricted stock that vested the same day. After this tax-withholding disposition, he directly owned 11,505 common shares.
Hanover Bancorp, Inc. president Wilcox McClelland W reported tax-related dispositions of company stock. On February 20, 2026, a total of 3,401 shares of common stock were withheld at $21.98 per share to cover taxes on vested restricted stock grants from 2022–2025. After these tax-withholding transactions, he directly owned 97,697 shares of Hanover Bancorp common stock.
Hanover Bancorp EVP and Chief Risk Officer John P. Vivona had 95 shares of common stock withheld for taxes in connection with restricted stock vesting. The tax-withholding disposition on restricted shares occurred on February 20, 2026 at a price of $21.98 per share. After this non‑open‑market transaction, he directly holds 5,152 shares of Hanover Bancorp common stock.
Hanover Bancorp (HNVR) insider activity centers on tax-related share dispositions, not open-market selling. First Senior Vice President and Chief Accounting Officer Lisa A. Diiorio used three small blocks of common stock on February 20, 2026 to cover tax withholding triggered by vesting of prior restricted stock awards. These tax-withholding dispositions, all coded as transaction type “F,” relate to grants made in 2025, 2024, and 2022. After these transactions, she directly owned 15,778 shares of Hanover Bancorp common stock.
Hanover Bancorp, Inc. executive Kevin Corbett, EVP & Chief Credit Officer, reported several Form 4 transactions involving common stock on February 20, 2026. These were tax-withholding dispositions, where shares were surrendered to cover tax liabilities upon the vesting of previously granted restricted stock. After these transactions, Corbett directly owned 27,936 shares of Hanover Bancorp common stock.
Hanover Bancorp, Inc. director Philip A. Okun reported receiving a grant of 1,592 shares of common stock on February 5, 2026. The shares are restricted stock awarded at a price of $0.0000 per share and are subject to forfeiture.
The grant vests over three years, with one-third of the shares vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. Following this award, Okun beneficially owns 42,669 shares of Hanover Bancorp common stock in direct ownership.
Hanover Bancorp, Inc. director Michael David Katz, M.D. reported receiving a grant of 1,592 shares of common stock on February 5, 2026 at a price of $0.0000 per share. These restricted shares are subject to forfeiture and vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.
After this grant, he directly holds 152,202 common shares, and also has indirect holdings of 25 shares as custodian for Grandchild #1, 40 shares as custodian for Grandchild #2, and 96,760 shares as beneficiary of a trust.
Hanover Bancorp, Inc. reported that its EVP & Chief Risk Officer, John P. Vivona, received a grant of 1,338 shares of common stock on February 5, 2026. The shares were granted at a price of $0.0000 per share as restricted stock subject to forfeiture.
The grant vests over three years, with one-third of the shares vesting on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. Following this award, Vivona beneficially owns 5,247 shares of Hanover Bancorp common stock, held directly.
Hanover Bancorp director Elena Sisti reported a grant of 1,592 shares of common stock. The shares are restricted stock granted at a price of $0.00 per share and are subject to forfeiture. They will vest over three years, with one-third vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029.
After this award, Sisti directly beneficially owns 105,016 shares of Hanover Bancorp common stock. An additional 51,018 shares are reported as indirectly owned through her spouse.
Hanover Bancorp, Inc. director Robert Golden reported a mix of stock awards and sales. On February 5, 2026, he received 1,592 shares of restricted common stock at $0.0000 per share, vesting in equal thirds on March 1 of 2027, 2028, and 2029. That award brought his directly held shares to 26,268.
On February 5 and 6, 2026, trusts for his benefit, where his spouse is trustee, sold 500 shares at $23.50 and 700 shares at $23.60, leaving 195,358 shares in those trusts. He also reports additional indirect holdings through various trusts, a controlled LLC, and his spouse, including 80,769 shares in trusts for a sibling and 25,000 shares held by his spouse.
Hanover Bancorp, Inc. director Abraham Varkey reported a grant of 1,592 shares of common stock on February 5, 2026 at a price of $0.0000 per share. These shares are restricted stock subject to forfeiture.
The restricted stock vests over three years, with one-third vesting on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. After this grant, Varkey beneficially owns 45,670 common shares directly and 13,334 common shares indirectly through his spouse.
Hanover Bancorp, Inc. director John R. Sorrenti reported an equity award of common stock. On February 5, 2026, he received 1,592 shares of restricted common stock at a price of $0.0000 per share, increasing his holdings to 47,209 common shares owned directly.
The award is structured as restricted stock subject to forfeiture and time-based vesting. The shares vest in three equal installments, with one-third scheduled to vest on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029, aligning director compensation with longer-term company performance.
Hanover Bancorp, Inc. reported an insider stock grant to executive Joseph F. Burns, its EVP & Chief Lending Officer. On February 5, 2026, he was awarded 2,592 shares of common stock at a price of $0.0000 per share as restricted stock subject to forfeiture.
The restricted shares vest over three years, with one-third vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. After this grant, Burns beneficially owns 11,693 shares of Hanover Bancorp common stock directly.
Hanover Bancorp, Inc. reported that its Senior Executive Vice President and Chief Financial Officer, Lance P. Burke, received an equity grant in the form of restricted common stock. He was awarded 3,185 shares on February 5, 2026, at a price of $0.0000 per share, increasing his directly held beneficial ownership to 29,142 common shares.
The grant is structured to vest over three years, with one-third of the shares vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029, and is subject to forfeiture conditions typically tied to continued service or performance.
Hanover Bancorp executive Kevin Corbett reported an equity grant of company stock. As EVP & Chief Credit Officer, he received 2,198 shares of Hanover Bancorp common stock on February 5, 2026 at a price of $0.0000 per share, reflecting a restricted stock award rather than an open-market purchase.
These shares are subject to forfeiture and will vest over three years, with one-third scheduled to vest on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. Following this grant, Corbett directly holds 29,123 shares of Hanover Bancorp common stock.
Hanover Bancorp, Inc. director Ahron H. Haspel received a grant of 1,592 shares of common stock on February 5, 2026. The shares were granted at a price of $0.0000 per share as restricted stock subject to forfeiture.
The restricted stock vests over three years, with one-third vesting on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. After this award, Haspel directly beneficially owned 29,035 common shares and indirectly beneficially owned 39,673 common shares through an LLC.
Hanover Bancorp, Inc. director Metin Negrin received a grant of 1,592 shares of common stock on February 5, 2026. The grant is in the form of restricted stock subject to forfeiture.
The restricted shares vest over three years, with one-third vesting on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. Following this award, Negrin directly beneficially owns 238,647 shares of Hanover Bancorp common stock.
Hanover Bancorp, Inc. reported that Chairman and CEO Michael P. Puorro received a grant of 10,945 shares of restricted common stock on February 5, 2026 at a price of $0.0000 per share. These shares are subject to forfeiture and vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. After this award, Puorro directly beneficially owns 326,046 shares of Hanover Bancorp common stock.
Hanover Bancorp, Inc. reported that officer Lisa A. DiIorio, FSVP & Chief Accounting Officer, received a grant of 1,062 shares of common stock on February 5, 2026 at a price of $0.0000 per share. This restricted stock award is subject to forfeiture and will vest in three equal installments, with one-third vesting on March 1, 2027, one-third on March 1, 2028, and one-third on March 1, 2029. Following this grant, she beneficially owns 16,365 shares of Hanover Bancorp common stock, held directly.
Hanover Bancorp (HNVR) director reported an open-market sale of 5,000 shares of common stock on 11/04/2025 at $21.2495 per share.
Following the transaction, reported beneficial ownership includes 24,676 shares held directly and multiple indirect positions. Examples include 80,769 shares held in various trusts for a sibling (trustee role noted), 196,558 shares held in trusts for the reporting person (spouse as trustee), and stakes via entities and family trusts as detailed in the footnotes.